|
|
Volumn 686, Issue 2, 1996, Pages 241-248
|
|
Validation of a high-performance liquid chromatographic-mass spectrometric method for the measurement of 5-chloro-2',3'dideoxy-3'-fluorouridine (935U83) in human plasma
a
a
|
|
Author keywords
5 Chloro 2',3' dideoxy 3' fluorouridine; 5 Chloro 2',3' dideoxy 5' O D glucopyranuronosyl 3' fluorouridine
|
|
Indexed keywords
DRUG METABOLITE;
RALURIDINE;
ACCURACY;
ARTICLE;
CALIBRATION;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
DOSE RESPONSE;
DRUG BLOOD LEVEL;
DRUG DETERMINATION;
DRUG STABILITY;
FEMALE;
HIGH PERFORMANCE LIQUID CHROMATOGRAPHY;
HUMAN;
HUMAN EXPERIMENT;
HUMAN IMMUNODEFICIENCY VIRUS INFECTION;
HUMAN TISSUE;
MALE;
MASS SPECTROMETRY;
NORMAL HUMAN;
ORAL DRUG ADMINISTRATION;
PHASE 1 CLINICAL TRIAL;
PRIORITY JOURNAL;
QUANTITATIVE ASSAY;
REVERSED PHASE HIGH PERFORMANCE LIQUID CHROMATOGRAPHY;
SOLID PHASE EXTRACTION;
TECHNIQUE;
ANTIVIRAL AGENTS;
CHROMATOGRAPHY, HIGH PRESSURE LIQUID;
DIDEOXYNUCLEOSIDES;
HUMANS;
MASS SPECTROMETRY;
REPRODUCIBILITY OF RESULTS;
SENSITIVITY AND SPECIFICITY;
|
|
EID: 0030588944
PISSN: 15726495
EISSN: None
Source Type: Journal
DOI: 10.1016/S0378-4347(96)00226-5 Document Type: Article |
|
Times cited : (3)
|
|
References (3)
|
